Conferences
30 September 2024, Online
Journal of Clinical Medicine Webinar | NSCLC Treatment from the Early Stage to the Locally Advanced Disease in the New Era of Drugs, 30 September 2024
MDPI would like to invite all experts recognized in their fields to attend the webinar organized by the Journal of Clinical Medicine (JCM, ISSN: 2077-0383), entitled Non-Small Cell Lung Cancer (NSCLC) Treatment from the Early Stage to the Locally Advanced Disease in the New Era of Drugs. The aim of the webinar is to focus on the latest NSCLC management strategies, including the shift from traditional platinum-based chemotherapy to novel immunotherapies and targeted treatments. Discussions will address the critical decision between neoadjuvant and adjuvant approaches, emphasizing the importance of multidisciplinary collaboration among oncologists, thoracic surgeons, radiologists, and pathologists to optimize patient outcomes through tailored treatment plans and seamless care transitions.
We are looking forward to seeing you at the webinar NSCLC Treatment from the Early Stage to the Locally Advanced Disease in the New Era of Drugs.
Webinar: NSCLC Treatment from the Early Stage to the Locally Advanced Disease in the New Era of Drugs
Date: 30 September 2024
Time: 10:00–12:00 (CEST) | 16:00–18:00 (CST Asia)
More information: https://sciforum.net/event/JCM-10
This is a free webinar. After registration, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.
Unable to attend? Register anyway and we will let you know when the recording is available for viewing.
Register for free:
Program:
|
Speaker/Presentation |
Time in CEST |
CST Asia |
|
Dr. Monica Casiraghi Chair Introduction |
10:00–10:10 |
16:00–16:10 |
|
Dr. Monica Casiraghi Role of Surgery in eNSCLC and Outcomes: Indications for Neoadjuvant and Adjuvant Treatments |
10:10–10:25 |
16:10–16:25 |
|
Dr. Luca Bertolaccini Unlocking the Potential: Artificial Intelligence in the Multidisciplinary Lung Cancer Management |
10:25–10:40 |
16:25–16:40 |
|
Prof. Dr. Paul E.Y. Van Schil Sublobar Resection for Small NSCLC < 2 cm: Is It a Valid Oncological Treatment? |
10:40–10:55 |
16:40–16:55 |
|
Prof. Dr. Mohsen Ibrahim Surgery for Locally Advanced NSCLC |
10:55–11:10 |
16:55–17:10 |
|
Prof. Dr. Isabelle Opitz Challenging Pulmonary Resections in the New IO Era |
11:10–11:25 |
17:10–17:25 |
|
Q&A Session |
11:25–11:50 |
17:25–17:50 |
|
Dr. Monica Casiraghi Closing of Webinar |
11:50–12:00 |
17:50–18:00 |
Relevant Special Issue:
“Prevention, Diagnosis and Treatments of Early-Stage NSCLC: New Advances and Future Prospective”
Edited by Monica Casiraghi
Submission Deadline: 20 October 2024
